Study design and patients
SECONDARY
This study represents a secondary analysis of the VIDEX trial (registration number: NL47786.048.14, EudraCT Number: 2014-000047-33) [Overview of the study designOf the 177 patients included in the study, PRE-XT samples were not available for 4 persons. In addition, samples from a total of 13 patients were lost to follow-up and had neither POST-XT nor FU samples available. Furthermore, patients who failed to complete a minimum of 80% of the scheduled home training program during the 6 months between POST-XT and FU were excluded from the analysis. Thus, 145 patients were analyzed, hereunder 76 patients in the HI RT group and 69 patients in the LI RT group. The CONSORT diagram is shown in Fig. CONSORT diagram of the study patients